CareRx Corporation
CRRX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 267.68M | 268.79M | 270.63M | 273.75M | 274.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 267.68M | 268.79M | 270.63M | 273.75M | 274.77M |
| Cost of Revenue | 188.81M | 190.57M | 191.97M | 195.46M | 197.18M |
| Gross Profit | 78.87M | 78.22M | 78.66M | 78.29M | 77.60M |
| SG&A Expenses | 73.89M | 72.00M | 72.79M | 72.57M | 72.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 262.70M | 262.57M | 264.76M | 268.03M | 269.72M |
| Operating Income | 4.98M | 6.22M | 5.86M | 5.72M | 5.06M |
| Income Before Tax | -3.24M | -4.50M | -5.31M | -5.89M | -7.10M |
| Income Tax Expenses | 22.90K | -127.20K | -127.20K | -3.12M | -3.12M |
| Earnings from Continuing Operations | -3.26 | -4.37 | -5.18 | -2.77 | -3.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.26M | -4.37M | -5.18M | -2.77M | -3.98M |
| EBIT | 4.98M | 6.22M | 5.86M | 5.72M | 5.06M |
| EBITDA | 16.19M | 17.56M | 16.03M | 17.00M | 16.99M |
| EPS Basic | -0.05 | -0.07 | -0.09 | -0.05 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.03 | -0.04 | -0.05 |
| EPS Diluted | -0.05 | -0.07 | -0.09 | -0.05 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.03 | -0.03 | -0.05 |
| Average Basic Shares Outstanding | 241.02M | 238.73M | 236.38M | 233.91M | 229.37M |
| Average Diluted Shares Outstanding | 241.02M | 238.73M | 236.38M | 239.42M | 234.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |